Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis

Objective: To determine whether characterisation of patients' metabolic profiles, utilising nuclear magnetic resonance (NMR) and mass spectrometry (MS), could predict response to rituximab therapy. 23 patients with active, seropositive rheumatoid arthritis (RA) on concomitant methotrexate were...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweeney, Shannon R, Kavanaugh, Arthur, Lodi, Alessia, Wang, Bo, Boyle, David, Tiziani, Stefano, Guma, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013418/
https://www.ncbi.nlm.nih.gov/pubmed/27651926
http://dx.doi.org/10.1136/rmdopen-2016-000289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013418/
https://www.ncbi.nlm.nih.gov/pubmed/27651926
http://dx.doi.org/10.1136/rmdopen-2016-000289

Ejemplares similares